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A recurrent mutation in CACNA1G alters Cav3.1 T-type calcium channel 
conduction and causes autosomal dominant cerebellar ataxia 
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Summary 
Hereditary cerebellar ataxias (CA) are neurodegenerative disorders, clinically 
characterized by a cerebellar syndrome, often accompanied by other neurological or 
non-neurological signs. All transmission modes have been described. In autosomal 
dominant forms (ADCA), mutations in more than 30 genes are implicated, but the 
molecular diagnosis remains unknown in about 40% of the cases. Implication of ion 
channels has long been an on-going topic in the genetics of CA, and mutations in 
several channel genes have been recently connected to ADCA. 
In a large family with ADCA and mild pyramidal signs, we searched for the causative 
variant with a combined approach of linkage analysis and whole exome sequencing. 
We identified a NM_018896.4:c.5144G>A mutation in CACNA1G, causing an 
arginine-to-histidine (p.Arg1715His) change in the voltage-sensor/segment S4 of the 
T-type Cav3.1 channel protein. Two out of 479 index cases screened subsequently 
harbored the same mutation. Electrophysiological experiments were performed in 
HEK293T cells to compare the properties of the p.Arg1715His and the wild-type 
Cav3.1 channels. The current-voltage and the steady-state activation curves of the 
p.Arg1715His channel were shifted positively, while the inactivation curve had a 
higher slope factor. Computer modelisation in deep cerebellar nuclei neurons 
suggested that the mutation results in decreased neuronal excitability. 
Taken together, these data establish CACNA1G, which is highly expressed in the 
cerebellum, as a gene whose mutations can cause ADCA. This is consistent with the 
neuropathological examination showing severe Purkinje cell loss. Our study further 
extends our knowledge of the link between calcium channelopathies and CA. 
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Hereditary cerebellar ataxias are rare clinically and genetically heterogeneous 
neurodegenerative disorders.
1
 They are characterized by a cerebellar syndrome, 
associated with other neurological or extra-neurological symptoms, and are inherited 
in all classical transmission modes. In autosomal dominant cerebellar ataxias 
(ADCA), the most frequent mutations are trinucleotide CAG repeat expansions, 
present in seven genes
2
, coding for a polyglutamine stretch in the corresponding 
proteins. Next mutations in frequency are noncoding nucleotide expansions and 
conventional mutations that have been described in more than 20 different genes. The 
causative variant remains unknown, however, in about 40% of individuals with 
ADCA.
2; 3
 
 
Over the last few years, next generation sequencing has led to the 
identification of an increasing number of variants in many genes implicated in this 
pathology.
4
 Mutations in multiple genes gathered in various common pathways have 
highlighted their importance in the physiopathology of ADCAs, including channels. 
The first channel-coding gene to be involved in ADCAs was CACNA1A (MIM 
*601011), encoding the P/Q-type voltage-gated calcium channel; small polyglutamine 
expansions, loss-of-function mutations, or missense variants in this gene give rise to 
Spinocerebellar Ataxia type 6 (MIM #183086), Episodic Ataxia type 2 (MIM 
#108500), or Familial Hemiplegic Migraine type 1 (MIM #141500).
5; 6
 Knockdown of 
the fibroblast growth factor gene, FGF14 (MIM *601515), responsible for SCA27 
(MIM #609307), reduces calcium currents in granule cells.
7
 Mutations in other ion 
channel genes have also been described, including the voltage-gated potassium 
channel genes KCNC3/SCA13 (MIM *176264/#605259)
8
 and KCND3/SCA19-22 
(MIM *605411/#607346),
9; 10
 and the ligand-gated ion channel genes ITPR1/SCA15 
(MIM *147265/#606658) and GRID2 (MIM *602368).
1; 11; 12
 All these findings 
converge to emphasize the importance of ion balance, notably that of calcium ions, in 
cerebellar physiology.
13
 
 
In this paper, we report three pedigrees segregating ADCA, with a recurrent 
mutation inducing an amino acid change in the voltage sensor S4 segment of domain 
IV in Cav3.1, a T-type calcium channel encoded by CACNA1G (MIM *604065). We 
present electrophysiological in vitro evidence that this p.Arg1715His (NM_018896.4) 
variant alters the channel activity, shifting its steady-state activation curve towards 
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more positive values and changing its inactivation slope constant. In an in silico 
model of deep cerebellar nuclei neurons, we establish decreased excitability linked to 
these altered parameters. Altogether, we describe a monogenic disease linked to 
CACNA1G mutations; confirm the implication of Cav3.1 channels, highly expressed 
in Purkinje cells and deep cerebellar nuclei neurons, in cerebellar physiology; and 
strengthen the gathering of evidence towards the prominence of calcium levels in 
cerebellar ataxia pathophysiology. 
 
Families AAD-SAL-233, AAD-GRE-319, and AAD-SAL-454 were part of 
the Spastic Paraplegia and ATAXia (SPATAX) network cohort, along with more than 
500 other ADCA pedigrees. Affected members and relatives were examined and 
blood was taken after informed consent, according to French legislation (Paris Necker 
ethics committee approval to A. Brice and A. Durr, RBM 01-29 and RBM 03-48). All 
clinical data are summarized in Table 1. The age at onset varied widely, ranging from 
9 to 78 years; gait instability was the major presenting symptom (9/10). Even after 
decades of progression, the disability and symptoms remained mild to moderate, 
indicating stable cerebellar involvement. Ocular signs, including saccadic pursuit, 
horizontal nystagmus and transient diplopia, were often noted (7/10). Interestingly, 
pyramidal signs, ranging from reflex pyramidal syndrome to spastic gait, were present 
in 5/10 individuals. Of note, depression was reported in 3/10 individuals, and 
cognitive impairment in 2/10. When performed (n=5), MRI revealed predominantly 
vermian cerebellar atrophy and a normal pons (Figure S1). 
 
Individual AAD-SAL-233-14 (III-9 in Figure 2) had signed an informed 
consent for brain donation. She died at age 83. The left hemi-brain was examined, 
while samples from the right hemi-brain were frozen and kept in the brain bank GIE 
NeuroCEB (Bioresource Research Impact Factor number = BRIF BB-0033-00011), 
declared to the Ministry of Research and Higher Education as required by the French 
law. The Brain Bank has been officially authorized to provide samples to scientists 
(agreement AC-2007-5). Macroscopically, the cerebellar hemisphere and the vermis 
were respectively mildly and severely atrophic. The cerebral cortex appeared normal. 
Microscopically, the volume of the cerebellar white matter was reduced. Bergmann 
gliosis and empty baskets were evidences of loss of Purkinje cells, more prominent in 
the vermis. In the granular layer, the number of glomeruli was decreased. The cellular 
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density was increased in the molecular layer, which appeared loosened (Figure 1). 
Unusually abundant polyglycosan bodies were observed in all cerebellum layers. The 
neuronal density in the dentate nucleus was normal as was the density of myelinated 
axons in the hilus. There was no neuronal loss in the pontine nuclei. The number of 
neurons was reduced in the inferior olive, which appeared gliotic. The substantia 
nigra was normal.  
 Microscopic evidences of Alzheimer’s disease (MIM  
#104300) were also observed, with amyloid deposits in the cerebral cortex, the 
hippocampus and the basal ganglia (Thal phase 3 
14
). Tau positive neurofibrillary 
tangles, neuropil threads and senile plaques coronae were seen in the entorhinal cortex 
and hippocampus. Associative cortices were mildly affected and primary cortices, 
spared (Braak stage V 
15
).  
 
Polyglutamine and C9orf72 (MIM *614260) expansions had previously been 
excluded in all three index cases using classical procedures. Linkage analysis was 
performed in family AAD-SAL-233 (Figure S2). Six major putative loci were 
detected, with maximal multipoint LOD scores ranging from +1.579 to +2.279. 
Whole exome sequencing was performed in individuals AAD-SAL-233-15 (III-10 in 
Figure 2) and AAD-SAL-233-25 (IV-16 in Figure 2), with 85 to 87% 30x-coverage, 
through enrichment capture using the Sure Select All Exon 50Mb kit (Agilent) 
followed by 2x75bp massive parallel sequencing in the Hiseq2000 sequencer 
(Illumina) (Table S1). Results were analyzed using the following criteria: effect on 
the coding sequence of an established protein-coding gene, heterozygous state in 
affected individual 25 and absent from healthy individual 15, location within the non-
excluded loci, frequency under 0.1% in public databases (dbSNP137, Exome Variant 
Server, EXome Aggregation Consortium). Sanger validation and segregation study in 
all family members led to the identification of two candidate variants: a 
chr10:g.95372766G>A, NM_006204.3: c.284G>A: p.Arg95His change in PDE6C 
(MIM *600827) and a chr17: g.48694921G>A, NM_018896.4: c.5144G>A: 
p.Arg1715His change in CACNA1G (MIM *604065) (Figure 2, Table S2). Of note, 
PDE6C is much more tolerant to missense variations than CACNA1G, as estimated by 
Samocha et al.,
16
 with an observed to expected ratio of 236/261.5 (Z-score 0.77), 
compared to 598/903.6 (Z-score 4.97) for CACNA1G. 
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We then screened ADCA index cases for variants in CACNA1G (n=479), 
PDE6C and genes previously involved in ADCA (n=384), with amplicon-based panel 
sequencing techniques, either with conventional PCR amplification followed by GS 
Junior (Roche) sequencing (n=95) or microfluidic PCR amplification (Fluidigm 
Access Array) followed by MiSeq (Illumina) sequencing (n=384) according to the 
manufacturers protocols (Table S3). Results were analyzed using the above-
mentioned criteria. Two index cases, AAD-GRE-319-12 (II-2 in Figure 2), and AAD-
SAL-454-10 (III-1 in Figure 2), harbored the same CACNA1G NM_018896.4: 
c.5144G>A: p.Arg1715His variant. No recurrence of the abovementioned PDE6C 
variant was observed. All detected PDE6C variants, reported in Table S4, were 
present in public databases.  
No conventional mutations in genes previously involved in ADCA were found 
in AAD-GRE-319-12 (II-2 in Figure 2). AAD-SAL-454-10 (III-1 in Figure 2) also 
harbored a Variant of Unknown Significance (class 3 ACMG) in SPTBN2/SCA5 
(MIM *604985/#600224), chr11: 66455764, NM_006946.2: c.6250G>A: 
p.Glu2084Lys, not located within the spectrin repeats as previously described for all 
SPTBN2 mutations.
17
 It was reported at the heterozygous state in one individual in 
EVS and one other case in ExAC; almost all in silico prediction softwares matched to 
predict it to be tolerated (data not shown). No recurrence was observed in the other 
383 index cases tested.  
Segregation of the CACNA1G c.5144G>A (p.Arg1715His) variant was 
established in two additional affected members of family AAD-GRE-319 (Figure 2). 
Other individuals harbored various CACNA1G variants (Table S5); however, their 
pathogenic effects could not be ascertained, due to the lack of affected individuals for 
segregation studies, genetic elements suggesting deleterious effects, or 
electrophysiological anomalies (Table S6). Analysis of flanking variants identified 
two homozygous variants in the CACNA1G region (chr17:g.48652875A>G and 
chr17:g.48655493A>G) in individual AAD-SAL-454-10 (III-1 in Figure 2) that were 
absent in AAD-SAL-233-25 (IV-16 in Figure 2) and heterozygous in AAD-GRE-319-
12 (II-2 in Figure 2), excluding a common founder effect for all three families.  
We hence focused on the CACNA1G variant versus the PDE6C one, because 
of strict co-segregation with the disease, absence in public databases, more 
concordant pathogenicity prediction scores, slightly higher conservation scores (Table 
 7 
S2), lower tolerance to missense variation, extremely high expression in the 
cerebellum,
18-20
 and the previous implication of CACNA1A as well as other ion 
channels in cerebellar ataxias. 
 
To study the effect of the p.Arg1715His variant on the electrophysiological 
characteristics of Cav3.1, the c.5144G>A mutation was introduced into the cDNA of 
the human Cav3.1 channel (isoform 5, Uniprot O43497-1, 
21
) by site directed 
mutagenesis (QuickChange Lightning Site-Directed mutagenesis, Agilent 
technologies). The wild-type (WT) and mutant cDNA constructs were then 
transfected into HEK239T cells and macroscopic currents were recorded by whole-
cell patch clamp techniques. Figure 3A shows typical recordings of the calcium 
current generated by these channels. Several differences between the WT and the 
p.Arg1715His channel were observed. Notably, the aberrant channel exhibited a 
significant shift of the steady-state activation curve towards more positive membrane 
potential values. The half-activation potential changed from -47.20 ± 0.65 mV (n=18) 
for the WT to -43.27 ± 0.73 mV (n=16) (p<0.001) (Figure 3B). The steady-state 
inactivation curve was also affected. Although the half-inactivation potential was 
unchanged (-70.91 ± 0.48 mV [n=15] for the WT vs 70.68 ± 0.36 mV [n=16] for 
p.Arg1715His), the slope factor was significantly higher for the aberrant channel 
(5.39 ± 0.11 mV (n=16) compared to 4.29 ± 0.07 mV (n=15) for the WT, p<0.0001). 
As a consequence, the window current also shifted towards more positive membrane 
potentials (Figure 3D). No significant change was observed in current density or other 
biophysical properties of the channel, such as activation and inactivation kinetics 
(Figure 3E-F), recovery from inactivation (Figure 3G) or deactivation kinetics (Figure 
3H). T-type calcium channels, especially Cav3.1, are highly expressed in cerebellar 
neurons, including deep cerebellar nuclear (DCN) neurons
22
. To determine the 
functional consequences that the p.Arg1715His change could have on firing, we used 
a DCN computer model
23
, with both excitatory and inhibitory inputs from 150 mossy 
fibers and 450 Purkinje cell synapses respectively. Introduction of our experimental 
parameters for the steady state activation and inactivation curves in this model 
revealed alteration of DCN firing properties. Notably, the p.Arg1715His change led to 
a diminution of the number of spikes per burst (4 spikes compared to 5 for the WT, 
Figure 3I) and a delayed onset of burst firing, thus increasing the interval between the 
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bursts (Figure 3I). These results suggest that the p.Arg1715His channel is responsible 
for a decrease in the neuronal excitability. 
 
The Cav3.1 channel belongs to the family of voltage-gated calcium channels 
(VGCCs), a large family divided in two main subgroups: (i) low-voltage activated 
(LVA) VGCCs, also known as T-type, comprising the Cav3.1 encoded by CACNA1G, 
Cav3.2, and Cav3.3 isoforms; and (ii) high-voltage activated (HVA) VGCCs, further 
divided into L-type, P/Q-type, N-type and R-type depending on their sensitivity to 
pharmacological agents.
24-26
 VGCCs are major actors regulating the calcium entry 
into neurons, and in turn play predominant roles in membrane potential regulation, 
and also in the modulation of calcium signaling pathways, such as neurite 
outgrowth,
27
 calcium-dependent gene transcription, neurotransmitter release, or 
regulation of enzymes such as protein kinase C,
26
 whose gamma subunit is associated 
with Spinocerebellar Ataxia 14 (MIM #605361) when mutations occur in PRKCG 
(MIM *176980).
28
 The variety of coexisting subtypes and isoforms allows the 
establishment of highly specific neuronal firing patterns.
26; 29; 30
 
 
T-type Cav3 calcium channels differ from HVA-VGCCs by their ability to be 
activated and inactivated at low voltages, near the resting membrane potential, their 
faster recovery from inactivation, their slower deactivation, and a characteristic 
window current occurring in the range of the resting membrane potential of 
neurons.
31; 32
 In this respect, they act as pacemakers and excitability regulators,
26
 
allowing cells to be depolarized at needed membrane potential for other channels’ 
activation. This window current is also essential for the regulation of the intracellular 
calcium concentration.
33
 In neurons, they have two essential behaviors: triggering of a 
burst action potential following a low threshold calcium spike
25; 32
 and rebound burst 
firing.
26; 31; 32
 Of the three Cav3 isoforms, Cav3.1 is highly expressed in cerebellar 
neurons, as well as thalamic relay neurons,
18; 20
 where it plays a major role in the 
establishment of the slow (<1Hz) sleep oscillations of non-rapid eye movement sleep 
(REM).
31
 Gain-of-function variants are thought to participate in the spike-and-wave 
discharges of thalamocortical neurons in absence epilepsy through enhancement of 
thalamic oscillatory activities.
18; 25; 34; 35
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In the cerebellum, a comprehensive study of Cav3 isoforms expression in 
neurons revealed that their specific patterns are correlated to various 
electrophysiological phenotypes.
30
 In situ hybridization studies described CACNA1G 
mRNA in both Purkinje cells (PC) and deep cerebellar nuclei neurons (DCN).
20; 36
 In 
DCN, Cav3.1 is predominantly expressed in a subset of large neurons exhibiting a 
strong ability to generate rebound burst firing after hyperpolarization.
30; 37
 
Pharmacological evidences confirmed that these rebound bursts are mediated by T-
type calcium channels.
38
 They appear to be physiologically relevant and consistent 
with a response to inhibitory input from PCs.
39
 Their characteristics result from 
interplay between T-type channels and hyperpolarization-activated cyclic-nucleotide 
channels (HCN).
22; 39
 In PC, all three subtypes of Cav3 are expressed.
30
 Cav3.1 was 
found at the cell body as well as at the synapse between parallel fibers (PF) and PC
19
. 
At this synapse, Cav3 channels interact with intermediate conductance calcium-
activated potassium channels (IKCa) to suppress the temporal summation of 
background excitatory postsynaptic potentials from PF through an after 
hyperpolarization.
22; 40
 This is essential to allow the detection of sensory-relevant high 
frequency inputs.
22; 40
 Finally, PC burst firing was shown to rely on P/Q-type calcium 
current. In addition, T-type channels interact with large conductance calcium-
activated potassium channels (BK) to determine firing rate, burst duration and 
interburst interval.
41
 Therefore, T-type channels, Cav3 isoforms, and, more 
specifically, the Cav3.1 isoform, have major roles in the PF-PC-DCN signal 
processing. Of note, histologically, the neuronal density appeared normal in the 
dentate nucleus of our affected case; marked PC loss was observed. 
 
In mice, that show 93% Cav3.1 amino-acid sequence identity with humans, no 
spontaneous Cacna1g mutations have been reported; however, several models have 
been generated. Cacna1g null mice have no overt neurological phenotype, normal 
growth and normal brain pathology;
42
 in particular, they have no motor defects.
43
 
However, they present with a non-REM sleep disturbance,
44
 are resistant to 
pharmacologically induced absence seizures,
42
 show attenuated neuropathic pain,
45
 
and present bradycardia and slowed atrioventricular conduction.
46
 The only cerebellar 
anomaly linked to Cacna1g inactivation was a loss of Purkinje cells in double mutant 
mice lacking both Cav3.1 and the alpha1 GABA-A receptor.
43
 In this mouse model, 
motor defects, including tremor, were exacerbated compared to mice lacking only the 
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GABA-A receptor. Conversely, transgenic mice overexpressing Cav3.1 show 
spontaneous spike-and-wave discharges associated with behavioral arrest.
18
  
 
In human pathology, the role of T-type VGCCs has only been partially 
elucidated. In particular, no monogenic disease has clearly been linked to T-type 
channel gene mutations until now.
25; 47
 CACNA1H (MIM *607904)/Cav3.2 is 
implicated in absence epilepsy (MIM #611942),
48-50
 with several mutations leading to 
increased activity of the channel
51
. However, in many cases, the variant rather induces 
susceptibility to seizures rather than has a monogenic causative effect.
25; 49
 As for 
CACNA1G, some variants have been described in Idiopathic Generalized Epilepsy 
(MIM %600669);
52
 many if not all of them appear to be risk factor variants and not 
causative mutations. CACNA1G was also associated with autism spectrum disorder 
(MIM %209850), but the association was too weak to fully explain the odds ratio.
53
 
Finally, a large study on intellectual disability identified a homozygous CACNA1G 
frameshift variant in three siblings with associated cataracts, but no reported 
cerebellar ataxia.
54
  
 
Despite its predominant expression in PC and DCN neurons, CACNA1G was 
never implicated by itself in cerebellar dysfunction. In three independent ADCA 
families, we describe the recurrent p.Arg1715His variant in Cav3.1. There are strong 
genetic arguments in favor of the deleteriousness of this variant: 1/ concordance of all 
in silico pathogenicity predictions; 2/ absence in all examined public databases (more 
than 60k exomes); 3/ amino acid conservation in all orthologs, paralogs, and S4 
segments of all four domains of the protein; 4/ location within a putatively linked 
locus (Figure S2); 5/ absence of pathogenic variants in all genes previously involved 
in ADCA; 6/ recurrence of the mutation in three pedigrees with exclusion of a 
common founder effect; 7/ perfect segregation in both pedigrees where it could be 
verified; and 8/ location within a functionally important domain of the protein, the 
voltage sensor S4 segment. Importantly, in vitro studies showed that the variant 
altered electrophysiological characteristics of the channel, with activation at more 
positive voltages, an increased slope factor of the steady-state inactivation curve and, 
consequently, a shift of the window current towards more positive potentials. Minimal 
alterations in T-type VGCC properties can lead to marked alterations in firing 
dynamics.
55
 Simulation of a DCN neuron activity carrying either WT or 
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p.Arg1715His Cav3.1 parameters also revealed a difference in burst firing, suggesting 
a reduced neuronal excitability caused by the aberrant channel. As activity of the 
cerebellar DCN and PC neurons is involved in movement behavior,
56; 57
 our findings 
suggest that the p.Arg1715His change of Cav3.1 could affect motor control by 
altering DCN activity.  
 
All together, these elements establish CACNA1G mutations as a monogenic 
cause of ADCA, with a recurrence of the p.Arg1715His variant and a relatively high 
frequency of almost 0.6%, in our cohort, after exclusion of polyglutamine expansions 
(~0.3% of all ADCA). The other variants detected (Table S5) could be either benign 
polymorphisms, variants that potentiate other ion channel variants such as loss-of-
function CACNA1A mutations, or causative mutations. Further investigations will be 
needed to elucidate their effects.  
 
Interestingly, the clinical picture in the families we describe does not include 
any form of epilepsy. Indeed, the p.Arg1715His variant induces a shift of activation 
towards positive voltages, while epilepsy-associated T-type channel variants are 
classically associated with a gain-of-function, through faster activation, negative shift 
of steady-state activation/inactivation properties, or increased protein expression.
25; 51
 
In agreement with these observations, CACNA1G KO mice are resistant to induced 
seizures.
42
 Expectedly, a positive shift in activation properties, as in our families, 
should be protective or have no effect.  
 
It is of note that, in family AAD-SAL-233, individual 14 (III-9 in Figure 2) 
presented with both clinical signs and pathology characteristic of Alzheimer’s disease 
(AD). Another family member presented with ataxia and Alzheimer’s type dementia, 
but no DNA was available for sequencing and the brain was not available. 
Downregulation of CACNA1G and Cav3.1 inhibition were recently correlated, in 
microarrays of human tissue, mice, and cellular models, with altered APP processing, 
and consequently, occurrence of AD.
58
 We could not determine whether the 
p.Arg1715His change was related to AD in this case. Nevertheless, the co-occurrence 
of AD at age 83 is not unexpected. 
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It is interesting to notice that the variant we describe, p.Arg1715His, is 
modifying a highly conserved arginine in the S4 segment of the domain IV of the 
channel. All T-type channels share a common general membrane topology with four 
domain repeats, each including six transmembrane segments (S1 to S6). S4 segments, 
through their positive arginine residues, are considered the voltage sensing elements, 
and their alteration is expected to affect the voltage dependency of the channel. A 
systematic mutagenesis study in Cav3.1 showed that loss of the outermost arginine 
residues in the voltage sensor S4 segment of domain IV affects the steady-state 
inactivation curve.
59
 Our results establish that Arg1715, the third outermost arginine 
in domain IV (R3), also plays a role in Cav3.1 gating by shifting the steady-state 
activation curve and changing the slope of the steady-state inactivation curve. This is 
consistent with the observation, in Cav3.2, that the equivalent arginine to histidine 
change (R3), also induces a positive shift in the steady-state activation curve of the 
protein at pH6.5,
60
 what would be expected when eliminating one of the segment S4 
arginines.  
 
In conclusion, we report three ADCA families in which a common variant 
affecting an arginine residue in the voltage sensor S4 segment of domain IV in Cav3.1 
segregates with the disease. Genetic and electrophysiological evidence support the 
pathogenicity of this variant. These results underscore the prominent role of Cav3.1-
mediated calcium currents in the cerebellar physiology, while previous reports on 
dysfunctions of this channel focused on thalamocortical relay neurons. We describe a 
monogenic disease caused by T-type current alteration. Our results also underscore 
the important role played by segment S4 of domain IV in the gating properties of 
Cav3.1. Finally, we provide further evidence of the importance of ion channel 
function in the physiopathology of cerebellar ataxia, and, in particular, of calcium-
related pathways.  
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Supplemental Data 
Supplemental Data include three figures and six tables and can be found with this 
article online.  
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Table 1. Clinical characteristics of affected individuals from families AAD-SAL-233, AAD-GRE-319, and AAD-SAL-454 
    
Individua
l N°*  
(sex) 
AAD-
SAL-
233-9, 
III-3 (F) 
AAD-
SAL-233-
14, 
III-9 (F) 
AAD-
SAL-233-
20, 
IV-4 (M) 
AAD-SAL-233-25, 
IV-16 (F) 
AAD-SAL-233-45, 
V-5 (F) 
AAD-
SAL-233-
46, 
V-6 (F) 
AAD-GRE-319-12, 
II-2 (F) 
AAD-
GRE-
319-13, 
III-2 (M) 
AAD-
GRE-
319-14, 
II-1 (F) 
AAD-SAL-454-10, 
III-1 (M) 
Age at 
exam 
(years) 
73 
(1998) 
82 (2012) 43 (1999) 42 (1999) 53 (2012) 
28 
(2001) 
39 (2012) 32 (2009) 57 (1998) 
69 
(2012) 
72-74 
(2013-
2015) 
51 (2015) 
79 
(2015) 
37 (2000) 47 (2010) 
Age at 
onset 
(years) 
20 68 41 9 19 18 37 40 78 30 
Disease 
duration 
(years) 
53 14 2 33 41 9 20 18 20 32 35-37 11 1 7 17 
Symptom
s at onset 
Vertigo 
Gait 
instability 
Gait 
instability 
Gait instability, vertigo Gait instability 
Gait 
instability 
Gait instability 
Gait 
instability 
Gait 
instabilit
y 
Gait instability 
Disability 
score 
4/7 4/7 1/7 3/7 3/7 2/7 2/7 2/7 4/7 5/7 5/7 3/7 2/7 2/7 3/7 
Cerebella
r 
syndrome 
(SARA 
score) 
Modera
te 
Yes Mild Mild 
Yes 
(20/40) 
Yes 
Mild 
(12.5/40) 
Mild Yes 
Yes 
(21/40) 
20.5/40 12/40 4/40 Yes 
Yes 
(12/40) 
Cerebella
r signs 
UL 
Yes NA No No Yes No Yes Yes No Mild Mild Mild No No Yes 
Dysarthri
a 
Severe No Yes Yes Yes No Yes Yes Yes Moderate Moderate Moderate No Yes Yes 
 15 
Ocular 
signs 
Limited 
upward 
gaze 
NA None 
Intermitte
nt 
diplopia  
Hypo 
metric 
saccades, 
square 
waves 
Saccadi
c 
pursuit 
Hypometr
ic 
saccades 
None 
Saccadic 
pursuit 
Saccadic 
pursuit 
Saccadic 
pursuit, 
diplopia,  
strabism 
Saccadic 
pursuit 
Saccadi
c pursuit 
Nystagm
us 
Nystagmus 
LL 
reflexes 
+ 
(Ankle-
) 
NA ++ ++ ++ + + N + N + N N N N 
Spastic 
gait 
No NA Mild Mild Mild   No No   No Mild No No No No 
UL 
reflexes 
N NA ++ ++ ++ N + N + N + N N N N 
Babinski 
sign 
No NA No Yes Yes No No No Unilateral No No No No Yes No 
Decreased 
vibration 
sense at 
ankles 
Yes NA Yes No No No Yes No No Mild Mild No Mild No Yes 
Urinary 
symptoms 
Urgenc
y 
NA No No 
Incontinen
ce 
No No No No No Urgency 
No; 
erectile 
dysfuncti
on 
Urgency Urgency 
Incontinen
ce 
Other 
Signs 
No NA No 
No 
(Myokym
ia 
orbicular) 
Postural  
UL and 
head 
tremor 
No No 
No 
(Myokym
ia 
orbicular) 
Scoliosis, 
Swallowi
ng 
difficultie
s 
Myokym
ia 
orbicular 
Dysphagia, 
dysarthria  
Dysphagi
a, 
dysarthria 
No No 
Swallowin
g 
difficulties
, Psoriasis 
Mood or 
Cognitive 
impairme
nt 
No 
Alzheime
r's disease 
Depression 
Depressio
n 
No No N No No No No No No 
MMS 
25/30, 
Depressi
on 
No 
 16 
Cerebral 
MRI 
NA NA 
Vermian 
atrophy 
less 
foliation of 
the 
hemispher
es, N-
acétyl-
aspartate 
decrease 
Vermian 
atrophy 
NA 
Vermia
n 
atrophy 
NA NA 
Vermian 
atrophy 
NA 
Cerebellar 
atrophy 
(vermian+
+), white 
matter 
hypersignal
s 
NA NA 
Vermian 
Atrophy 
Cerebellar 
and 
brainstem 
hypoplasia 
and 
atrophy 
F: female 
M: male 
NA: not available 
LL: lower limbs 
UL: upper limbs 
N: normal 
MMS: mini mental state 
MRI: magnetic resonance imaging 
SDFS score: Spinocerebellar Degeneration Functional Score 
 0: no functional handicap; 1: no functional handicap but signs at examination; 2: mild, able to run; 3: moderate, unable to run; 4: severe, 
walking with one stick, unlimited walking; 5: walking with two sticks; 6: unable to walk, requiring a wheelchair; 7: bedridden 
SARA score: Scale for the Assessment and Rating of Ataxia 
 
*Personal numbers are followed by pedigree numbers according to figure 2. 
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Figure 1. Neuropathologic examination of the cerebellum of individual AAD-
SAL-233-14 (III-9 in Figure 2) 
 
(A - B) Case; (C - D) Control. Hematoxylin and eosin staining. 
(A and C) Granular layer of the cerebellum. The black arrows in (C) point to normal 
glomeruli; normal glomeruli cannot be identified in (A). 
(B and D) Purkinje cell layer. Four normal Purkinje cells are visible in (D), one of 
which is indicated by a black arrow; Purkinje cell loss is severe in (B), only the 
processes of the basket cells are visible ("empty baskets", black arrows). Note the 
additional layer composed of Bergmann glia (white arrows). The asterisk in (B) and 
(D) indicates the molecular layer, which appears loosened in (B). 
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Figure 2. Segregation of the p.Arg1715His change in ADCA pedigrees and 
alignment of orthologs and paralogs 
 
(A) Pedigrees of ADCA families with the p.Arg1715His change. Number of affected 
individuals tested: six in AAD-SAL-233, three in AAD-GRE-319, one in AAD-SAL-
454. All affected but no unaffected individuals harbor the variant in the heterozygous 
state. 
(B) Chromatograms showing the mutation in individuals AAD-SAL-233-9 (III-3), 
AAD-GRE-319-12 (II-2), and AAD-SAL-454-10 (III-1). 
(C) Schematic representation of Cav3.1, showing its organization in four domains, 
each containing six transmembrane segments; segment S4 contains many positively 
charged aminoacids, such as arginine, and is therefore the voltage-sensor. The 
p.Arg1715His change is located in segment S4 of domain IV. Alignment of orthologs 
(D) and paralogs (E) shows that the arginine residues in Cav3.1 are very highly 
conserved across all species, T-type channels, and domains.  
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Figure 3. Electrophysiological analysis of WT and p.Arg1715His Cav3.1 calcium 
channels 
 
(A) Current traces obtained with wild-type (WT) and p.Arg1715His channels at 
various membrane potentials (-90, -80, -70, -65, -60, -55, -50, -45, -40, -35, -30, -25, -
20 mV) and from a holding potential of -100mV. Notice the trace in red (-50mV), 
which shows a smaller current for the pArg1715His channel (36% of the maximum 
current compared with 54% for the WT) 
(B) Averaged current-voltage relationships from traces in panel A. The normalized 
conductance-voltage curve fitted with a Boltzman equation: I/Imax=Gmax(Vm-
Erev)/(1+exp(V1/2-Vm)/k) for each individual cell.  
(C) Steady-state inactivation curves. The curves were fitted using 
I/Imax=1/(1+exp(Vm—V1/2)/k)  
(D) Availability of calcium currents (mean steady-state activation and inactivation 
curves). The steady-state activation curves were fitted with a Boltzmann equation 
G/Gmax=1/(1+exp(V1/2-Vm)/K) were G was calculated as follows: G=I/(Vm-Erev).  
(E and F) Time-constant of inactivation (τ inact) and activation (τ act) kinetics. The 
values were obtained by fitting the traces showed in panel A with a double 
exponential function. 
(G) Recovery from short-term inactivation using a two paired-pulse protocol  
(H) Deactivation kinetics (τ deact).   
(I) Simulation of a DCN neuron firing using the steady state activation and 
inactivation values obtained for the WT (black) and the p.Arg1715His (red) channels. 
The DCN model used was developed by Luthman et al.
23
 using the NEURON 
simulation environment (https://www.neuron.yale.edu/neuron/), based on the model 
originally implemented in GENESIS by Steuber et al.
61
 The NaP, HCN and CaLVA 
conductances were changed to match the “Neuron 1” model described by Steuber et 
al.
61
  
In the above-mentioned equations, V1/2 represents either the half-activation 
potential (steady-state activation curve) or the half-inactivation potential (steady-state 
inactivation curve). Other parameters are Vm, membrane potential; Erev, reversal 
potential; k, slope factor; G, conductance; Gmax, maximum conductance; I, current at 
a given Vm; Imax, maximum current. The extracellular solution contained (in mM): 
135 NaCl, 20 TEACl, 2 CaCl2, 1 MgCl2, 10 HEPES, pH adjusted to 7.44 with KOH. 
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Patch pipettes were filled with an internal solution (140 mM CsCl, 10 mM EGTA, 3 
mM CaCl2, 10 mM HEPES, 3 mM Mg-ATP, 0.6 mM GTP, pH adjusted to 7.25 with 
KOH) and had a typical resistance of 2-3MΩ. From B to H: WT values are 
represented with black circles and p.Arg1715His with red squares. Data are 
represented as mean ± SEM. 
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Web Resources 
The URLs for data presented herein are as follows: 
dbSNP137, http://www.ncbi.nlm.nih.gov/projects/SNP 
Exome Aggregation Consortium, http://exac.broadinstitute.org 
Exome Variant Server, http://evs.gs.washington.edu/EVS/ 
Online Mendelian Inheritance in Man (OMIM), http://www.omim.org 
Scale for the Assessment and Rating of Ataxia, http://www.ataxia-study-
group.net/html/about/ataxiascales/sara/SARA.pdf 
SPATAX, https://spatax.wordpress.com/ 
 
References 
1. Matilla-Duenas, A., Ashizawa, T., Brice, A., Magri, S., McFarland, K.N., Pandolfo, 
M., Pulst, S.M., Riess, O., Rubinsztein, D.C., Schmidt, J., et al. (2014). 
Consensus paper: pathological mechanisms underlying 
neurodegeneration in spinocerebellar ataxias. Cerebellum 13, 269-302. 
2. Durr, A. (2010). Autosomal dominant cerebellar ataxias: polyglutamine 
expansions and beyond. Lancet Neurol. 9, 885-894. 
3. Hersheson, J., Haworth, A., and Houlden, H. (2012). The inherited ataxias: 
genetic heterogeneity, mutation databases, and future directions in 
research and clinical diagnostics. Hum. Mutat. 33, 1324-1332. 
4. Coutelier, M., Stevanin, G., and Brice, A. (2015). Genetic landscape remodelling 
in spinocerebellar ataxias: the influence of next-generation sequencing. J. 
Neurol. Published online April 11, 2015 . http://dx.doi. 
org/10.1007/s00415-015-7725-4. 
5. Giunti, P., Mantuano, E., Frontali, M., and Veneziano, L. (2015). Molecular 
mechanism of Spinocerebellar Ataxia type 6: glutamine repeat disorder, 
channelopathy and transcriptional dysregulation. The multifaceted 
aspects of a single mutation. Front. Cell. Neurosci. 9, 36. 
6. Rajakulendran, S., Kaski, D., and Hanna, M.G. (2012). Neuronal P/Q-type 
calcium channel dysfunction in inherited disorders of the CNS. Nat. Rev. 
Neurol. 8, 86-96. 
7. Yan, H., Pablo, J.L., and Pitt, G.S. (2013). FGF14 regulates presynaptic Ca2+ 
channels and synaptic transmission. Cell. Rep. 4, 66-75. 
8. Waters, M.F., Minassian, N.A., Stevanin, G., Figueroa, K.P., Bannister, J.P., Nolte, 
D., Mock, A.F., Evidente, V.G., Fee, D.B., Muller, U., et al. (2006). Mutations 
in voltage-gated potassium channel KCNC3 cause degenerative and 
developmental central nervous system phenotypes. Nat. Genet. 38, 447-
451. 
9. Duarri, A., Jezierska, J., Fokkens, M., Meijer, M., Schelhaas, H.J., den Dunnen, 
W.F., van Dijk, F., Verschuuren-Bemelmans, C., Hageman, G., van de Vlies, 
P., et al. (2012). Mutations in potassium channel kcnd3 cause 
spinocerebellar ataxia type 19. Ann. Neurol. 72, 870-880. 
 22 
10. Lee, Y.C., Durr, A., Majczenko, K., Huang, Y.H., Liu, Y.C., Lien, C.C., Tsai, P.C., 
Ichikawa, Y., Goto, J., Monin, M.L., et al. (2012). Mutations in KCND3 cause 
spinocerebellar ataxia type 22. Ann. Neurol. 72, 859-869. 
11. Hills, L.B., Masri, A., Konno, K., Kakegawa, W., Lam, A.T., Lim-Melia, E., Chandy, 
N., Hill, R.S., Partlow, J.N., Al-Saffar, M., et al. (2013). Deletions in GRID2 
lead to a recessive syndrome of cerebellar ataxia and tonic upgaze in 
humans. Neurology 81, 1378-1386. 
12. Coutelier, M., Burglen, L., Mundwiller, E., Abada-Bendib, M., Rodriguez, D., 
Chantot-Bastaraud, S., Rougeot, C., Cournelle, M.A., Milh, M., Toutain, A., et 
al. (2015). GRID2 mutations span from congenital to mild adult-onset 
cerebellar ataxia. Neurology 84, 1751-1759. 
13. Chopra, R., and Shakkottai, V.G. (2014). Translating cerebellar Purkinje 
neuron physiology to progress in dominantly inherited ataxia. Future 
Neurol. 9, 187-196. 
14. Thal, D.R., Rub, U., Orantes, M., and Braak, H. (2002). Phases of A beta-
deposition in the human brain and its relevance for the development of 
AD. Neurology 58, 1791-1800. 
15. Braak, H., and Braak, E. (1991). Neuropathological stageing of Alzheimer-
related changes. Acta Neuropathol. 82, 239-259. 
16. Samocha, K.E., Robinson, E.B., Sanders, S.J., Stevens, C., Sabo, A., McGrath, L.M., 
Kosmicki, J.A., Rehnstrom, K., Mallick, S., Kirby, A., et al. (2014). A 
framework for the interpretation of de novo mutation in human disease. 
Nat. Genet. 46, 944-950. 
17. Ikeda, Y., Dick, K.A., Weatherspoon, M.R., Gincel, D., Armbrust, K.R., Dalton, 
J.C., Stevanin, G., Durr, A., Zuhlke, C., Burk, K., et al. (2006). Spectrin 
mutations cause spinocerebellar ataxia type 5. Nat. Genet. 38, 184-190. 
18. Ernst, W.L., Zhang, Y., Yoo, J.W., Ernst, S.J., and Noebels, J.L. (2009). Genetic 
enhancement of thalamocortical network activity by elevating alpha 1g-
mediated low-voltage-activated calcium current induces pure absence 
epilepsy. J. Neurosci. 29, 1615-1625. 
19. Ly, R., Bouvier, G., Schonewille, M., Arabo, A., Rondi-Reig, L., Lena, C., Casado, 
M., De Zeeuw, C.I., and Feltz, A. (2013). T-type channel blockade impairs 
long-term potentiation at the parallel fiber-Purkinje cell synapse and 
cerebellar learning. Proc. Natl. Acad. Sci. USA 110, 20302-20307. 
20. Talley, E.M., Cribbs, L.L., Lee, J.H., Daud, A., Perez-Reyes, E., and Bayliss, D.A. 
(1999). Differential distribution of three members of a gene family 
encoding low voltage-activated (T-type) calcium channels. J. Neurosci. 19, 
1895-1911. 
21. Monteil, A., Chemin, J., Bourinet, E., Mennessier, G., Lory, P., and Nargeot, J. 
(2000). Molecular and functional properties of the human alpha(1G) 
subunit that forms T-type calcium channels. J. Biol. Chem. 275, 6090-
6100. 
22. Engbers, J.D., Anderson, D., Zamponi, G.W., and Turner, R.W. (2013). Signal 
processing by T-type calcium channel interactions in the cerebellum. 
Front. Cell. Neurosci. 7, 230. 
23. Luthman, J., Hoebeek, F.E., Maex, R., Davey, N., Adams, R., De Zeeuw, C.I., and 
Steuber, V. (2011). STD-dependent and independent encoding of input 
irregularity as spike rate in a computational model of a cerebellar nucleus 
neuron. Cerebellum 10, 667-682. 
 23 
24. Perez-Reyes, E. (2006). Molecular characterization of T-type calcium 
channels. Cell Calcium 40, 89-96. 
25. Cain, S.M., and Snutch, T.P. (2011). Voltage-gated calcium channels and 
disease. Biofactors 37, 197-205. 
26. Simms, B.A., and Zamponi, G.W. (2014). Neuronal voltage-gated calcium 
channels: structure, function, and dysfunction. Neuron 82, 24-45. 
27. Hamid, J., Peloquin, J.B., Monteil, A., and Zamponi, G.W. (2006). Determinants 
of the differential gating properties of Cav3.1 and Cav3.3 T-type channels: 
a role of domain IV? Neuroscience 143, 717-728. 
28. Chen, D.H., Brkanac, Z., Verlinde, C.L., Tan, X.J., Bylenok, L., Nochlin, D., 
Matsushita, M., Lipe, H., Wolff, J., Fernandez, M., et al. (2003). Missense 
mutations in the regulatory domain of PKC gamma: a new mechanism for 
dominant nonepisodic cerebellar ataxia. Am. J. Hum. Genet. 72, 839-849. 
29. Chemin, J., Monteil, A., Perez-Reyes, E., Bourinet, E., Nargeot, J., and Lory, P. 
(2002). Specific contribution of human T-type calcium channel isotypes 
(alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability. J. Physiol. 
540, 3-14. 
30. Molineux, M.L., McRory, J.E., McKay, B.E., Hamid, J., Mehaffey, W.H., Rehak, R., 
Snutch, T.P., Zamponi, G.W., and Turner, R.W. (2006). Specific T-type 
calcium channel isoforms are associated with distinct burst phenotypes in 
deep cerebellar nuclear neurons. Proc. Natl. Acad. Sci. USA 103, 5555-
5560. 
31. Crunelli, V., Toth, T.I., Cope, D.W., Blethyn, K., and Hughes, S.W. (2005). The 
'window' T-type calcium current in brain dynamics of different 
behavioural states. J. Physiol. 562, 121-129. 
32. Perez-Reyes, E. (2003). Molecular physiology of low-voltage-activated t-type 
calcium channels. Physiol. Rev. 83, 117-161. 
33. Chemin, J., Monteil, A., Briquaire, C., Richard, S., Perez-Reyes, E., Nargeot, J., 
and Lory, P. (2000). Overexpression of T-type calcium channels in HEK-
293 cells increases intracellular calcium without affecting cellular 
proliferation. FEBS Lett. 478, 166-172. 
34. Shin, H.S., Cheong, E.J., Choi, S., Lee, J., and Na, H.S. (2008). T-type Ca2+ 
channels as therapeutic targets in the nervous system. Curr. Opin. 
Pharmacol. 8, 33-41. 
35. Yalcin, O. (2012). Genes and molecular mechanisms involved in the 
epileptogenesis of idiopathic absence epilepsies. Seizure 21, 79-86. 
36. Craig, P.J., Beattie, R.E., Folly, E.A., Banerjee, M.D., Reeves, M.B., Priestley, J.V., 
Carney, S.L., Sher, E., Perez-Reyes, E., and Volsen, S.G. (1999). Distribution 
of the voltage-dependent calcium channel alpha1G subunit mRNA and 
protein throughout the mature rat brain. Eur. J. Neurosci. 11, 2949-2964. 
37. Molineux, M.L., Mehaffey, W.H., Tadayonnejad, R., Anderson, D., Tennent, A.F., 
and Turner, R.W. (2008). Ionic factors governing rebound burst 
phenotype in rat deep cerebellar neurons. J. Neurophysiol. 100, 2684-
2701. 
38. Alvina, K., Ellis-Davies, G., and Khodakhah, K. (2009). T-type calcium channels 
mediate rebound firing in intact deep cerebellar neurons. Neuroscience 
158, 635-641. 
39. Engbers, J.D., Anderson, D., Tadayonnejad, R., Mehaffey, W.H., Molineux, M.L., 
and Turner, R.W. (2011). Distinct roles for I(T) and I(H) in controlling the 
 24 
frequency and timing of rebound spike responses. J. Physiol. 589, 5391-
5413. 
40. Engbers, J.D., Anderson, D., Asmara, H., Rehak, R., Mehaffey, W.H., Hameed, S., 
McKay, B.E., Kruskic, M., Zamponi, G.W., and Turner, R.W. (2012). 
Intermediate conductance calcium-activated potassium channels 
modulate summation of parallel fiber input in cerebellar Purkinje cells. 
Proc. Natl. Acad. Sci. USA 109, 2601-2606. 
41. Womack, M.D., and Khodakhah, K. (2004). Dendritic control of spontaneous 
bursting in cerebellar Purkinje cells. J. Neurosci. 24, 3511-3521. 
42. Kim, D., Song, I., Keum, S., Lee, T., Jeong, M.J., Kim, S.S., McEnery, M.W., and 
Shin, H.S. (2001). Lack of the burst firing of thalamocortical relay neurons 
and resistance to absence seizures in mice lacking alpha(1G) T-type 
Ca(2+) channels. Neuron 31, 35-45. 
43. Chang, K.Y., Park, Y.G., Park, H.Y., Homanics, G.E., Kim, J., and Kim, D. (2011). 
Lack of CaV3.1 channels causes severe motor coordination defects and an 
age-dependent cerebellar atrophy in a genetic model of essential tremor. 
Biochem. Biophys. Res. Commun. 410, 19-23. 
44. Lee, J., Kim, D., and Shin, H.S. (2004). Lack of delta waves and sleep 
disturbances during non-rapid eye movement sleep in mice lacking 
alpha1G-subunit of T-type calcium channels. Proc. Natl. Acad. Sci. USA 
101, 18195-18199. 
45. Na, H.S., Choi, S., Kim, J., Park, J., and Shin, H.S. (2008). Attenuated 
neuropathic pain in Cav3.1 null mice. Mol. Cells 25, 242-246. 
46. Mangoni, M.E., Traboulsie, A., Leoni, A.L., Couette, B., Marger, L., Le Quang, K., 
Kupfer, E., Cohen-Solal, A., Vilar, J., Shin, H.S., et al. (2006). Bradycardia 
and slowing of the atrioventricular conduction in mice lacking 
CaV3.1/alpha1G T-type calcium channels. Circ. Res. 98, 1422-1430. 
47. Bidaud, I., and Lory, P. (2011). Hallmarks of the channelopathies associated 
with L-type calcium channels: a focus on the Timothy mutations in 
Ca(v)1.2 channels. Biochimie 93, 2080-2086. 
48. Chen, Y., Lu, J., Pan, H., Zhang, Y., Wu, H., Xu, K., Liu, X., Jiang, Y., Bao, X., Yao, Z., 
et al. (2003). Association between genetic variation of CACNA1H and 
childhood absence epilepsy. Ann. Neurol. 54, 239-243. 
49. Heron, S.E., Phillips, H.A., Mulley, J.C., Mazarib, A., Neufeld, M.Y., Berkovic, S.F., 
and Scheffer, I.E. (2004). Genetic variation of CACNA1H in idiopathic 
generalized epilepsy. Ann. Neurol. 55, 595-596. 
50. Khosravani, H., Altier, C., Simms, B., Hamming, K.S., Snutch, T.P., Mezeyova, J., 
McRory, J.E., and Zamponi, G.W. (2004). Gating effects of mutations in the 
Cav3.2 T-type calcium channel associated with childhood absence 
epilepsy. J. Biol. Chem. 279, 9681-9684. 
51. Eckle, V.S., Shcheglovitov, A., Vitko, I., Dey, D., Yap, C.C., Winckler, B., and 
Perez-Reyes, E. (2014). Mechanisms by which a CACNA1H mutation in 
epilepsy patients increases seizure susceptibility. J. Physiol. 592, 795-809. 
52. Singh, B., Monteil, A., Bidaud, I., Sugimoto, Y., Suzuki, T., Hamano, S., Oguni, H., 
Osawa, M., Alonso, M.E., Delgado-Escueta, A.V., et al. (2007). Mutational 
analysis of CACNA1G in idiopathic generalized epilepsy. Mutation in brief 
#962. Online. Hum. Mutat. 28, 524-525. 
53. Strom, S.P., Stone, J.L., Ten Bosch, J.R., Merriman, B., Cantor, R.M., Geschwind, 
D.H., and Nelson, S.F. (2010). High-density SNP association study of the 
 25 
17q21 chromosomal region linked to autism identifies CACNA1G as a 
novel candidate gene. Mol. Psychiatry 15, 996-1005. 
54. Najmabadi, H., Hu, H., Garshasbi, M., Zemojtel, T., Abedini, S.S., Chen, W., 
Hosseini, M., Behjati, F., Haas, S., Jamali, P., et al. (2011). Deep sequencing 
reveals 50 novel genes for recessive cognitive disorders. Nature 478, 57-
63. 
55. Tscherter, A., David, F., Ivanova, T., Deleuze, C., Renger, J.J., Uebele, V.N., Shin, 
H.S., Bal, T., Leresche, N., and Lambert, R.C. (2011). Minimal alterations in 
T-type calcium channel gating markedly modify physiological firing 
dynamics. J. Physiol. 589, 1707-1724. 
56. Heiney, S.A., Wohl, M.P., Chettih, S.N., Ruffolo, L.I., and Medina, J.F. (2014). 
Cerebellar-dependent expression of motor learning during eyeblink 
conditioning in head-fixed mice. J. Neurosci. 34, 14845-14853. 
57. Witter, L., Canto, C.B., Hoogland, T.M., de Gruijl, J.R., and De Zeeuw, C.I. 
(2013). Strength and timing of motor responses mediated by rebound 
firing in the cerebellar nuclei after Purkinje cell activation. Front. Neural 
Circuits 7, 133. 
58. Rice, R.A., Berchtold, N.C., Cotman, C.W., and Green, K.N. (2014). Age-related 
downregulation of the CaV3.1 T-type calcium channel as a mediator of 
amyloid beta production. Neurobiol. Aging 35, 1002-1011. 
59. Kurejova, M., Lacinova, L., Pavlovicova, M., Eschbach, M., and Klugbauer, N. 
(2007). The effect of the outermost basic residues in the S4 segments of 
the Ca(V)3.1 T-type calcium channel on channel gating. Pflugers Arch. 
455, 527-539. 
60. Lam, A.D., Chikina, M.D., McNulty, M.M., Glaaser, I.W., and Hanck, D.A. (2005). 
Role of Domain IV/S4 outermost arginines in gating of T-type calcium 
channels. Pflugers Arch. 451, 349-361. 
61. Steuber, V., Schultheiss, N.W., Silver, R.A., De Schutter, E., and Jaeger, D. 
(2011). Determinants of synaptic integration and heterogeneity in 
rebound firing explored with data-driven models of deep cerebellar 
nucleus cells. J. Comput. Neurosci. 30, 633-658. 
 
 
 14 
Table 1. Clinical characteristics of affected individuals from families AAD-SAL-233, AAD-GRE-319, and AAD-SAL-454 
    
Individua
l N°*  
(sex) 
AAD-
SAL-
233-9, 
III-3 (F) 
AAD-
SAL-233-
14, 
III-9 (F) 
AAD-
SAL-233-
20, 
IV-4 (M) 
AAD-SAL-233-25, 
IV-16 (F) 
AAD-SAL-233-45, 
V-5 (F) 
AAD-
SAL-233-
46, 
V-6 (F) 
AAD-GRE-319-12, 
II-2 (F) 
AAD-
GRE-
319-13, 
III-2 (M) 
AAD-
GRE-
319-14, 
II-1 (F) 
AAD-SAL-454-10, 
III-1 (M) 
Age at 
exam 
(years) 
73 
(1998) 
82 (2012) 43 (1999) 42 (1999) 53 (2012) 
28 
(2001) 
39 (2012) 32 (2009) 57 (1998) 
69 
(2012) 
72-74 
(2013-
2015) 
51 (2015) 
79 
(2015) 
37 (2000) 47 (2010) 
Age at 
onset 
(years) 
20 68 41 9 19 18 37 40 78 30 
Disease 
duration 
(years) 
53 14 2 33 41 9 20 18 20 32 35-37 11 1 7 17 
Symptom
s at onset 
Vertigo 
Gait 
instability 
Gait 
instability 
Gait instability, vertigo Gait instability 
Gait 
instability 
Gait instability 
Gait 
instability 
Gait 
instabilit
y 
Gait instability 
Disability 
score 
4/7 4/7 1/7 3/7 3/7 2/7 2/7 2/7 4/7 5/7 5/7 3/7 2/7 2/7 3/7 
Cerebella
r 
syndrome 
(SARA 
score) 
Modera
te 
Yes Mild Mild 
Yes 
(20/40) 
Yes 
Mild 
(12.5/40) 
Mild Yes 
Yes 
(21/40) 
20.5/40 12/40 4/40 Yes 
Yes 
(12/40) 
Cerebella
r signs 
UL 
Yes NA No No Yes No Yes Yes No Mild Mild Mild No No Yes 
Dysarthri
a 
Severe No Yes Yes Yes No Yes Yes Yes Moderate Moderate Moderate No Yes Yes 
 15 
Ocular 
signs 
Limited 
upward 
gaze 
NA None 
Intermitte
nt 
diplopia  
Hypo 
metric 
saccades, 
square 
waves 
Saccadi
c 
pursuit 
Hypometr
ic 
saccades 
None 
Saccadic 
pursuit 
Saccadic 
pursuit 
Saccadic 
pursuit, 
diplopia,  
strabism 
Saccadic 
pursuit 
Saccadi
c pursuit 
Nystagm
us 
Nystagmus 
LL 
reflexes 
+ 
(Ankle-
) 
NA ++ ++ ++ + + N + N + N N N N 
Spastic 
gait 
No NA Mild Mild Mild   No No   No Mild No No No No 
UL 
reflexes 
N NA ++ ++ ++ N + N + N + N N N N 
Babinski 
sign 
No NA No Yes Yes No No No Unilateral No No No No Yes No 
Decreased 
vibration 
sense at 
ankles 
Yes NA Yes No No No Yes No No Mild Mild No Mild No Yes 
Urinary 
symptoms 
Urgenc
y 
NA No No 
Incontinen
ce 
No No No No No Urgency 
No; 
erectile 
dysfuncti
on 
Urgency Urgency 
Incontinen
ce 
Other 
Signs 
No NA No 
No 
(Myokym
ia 
orbicular) 
Postural  
UL and 
head 
tremor 
No No 
No 
(Myokym
ia 
orbicular) 
Scoliosis, 
Swallowi
ng 
difficultie
s 
Myokym
ia 
orbicular 
Dysphagia, 
dysarthria  
Dysphagi
a, 
dysarthria 
No No 
Swallowin
g 
difficulties
, Psoriasis 
Mood or 
Cognitive 
impairme
nt 
No 
Alzheime
r's disease 
Depression 
Depressio
n 
No No N No No No No No No 
MMS 
25/30, 
Depressi
on 
No 
 16 
Cerebral 
MRI 
NA NA 
Vermian 
atrophy 
less 
foliation of 
the 
hemispher
es, N-
acétyl-
aspartate 
decrease 
Vermian 
atrophy 
NA 
Vermia
n 
atrophy 
NA NA 
Vermian 
atrophy 
NA 
Cerebellar 
atrophy 
(vermian+
+), white 
matter 
hypersignal
s 
NA NA 
Vermian 
Atrophy 
Cerebellar 
and 
brainstem 
hypoplasia 
and 
atrophy 
F: female 
M: male 
NA: not available 
LL: lower limbs 
UL: upper limbs 
N: normal 
MMS: mini mental state 
MRI: magnetic resonance imaging 
SDFS score: Spinocerebellar Degeneration Functional Score 
 0: no functional handicap; 1: no functional handicap but signs at examination; 2: mild, able to run; 3: moderate, unable to run; 4: severe, 
walking with one stick, unlimited walking; 5: walking with two sticks; 6: unable to walk, requiring a wheelchair; 7: bedridden 
SARA score: Scale for the Assessment and Rating of Ataxia 
 
*Personal numbers are followed by pedigree numbers according to figure 2. 
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Figure 1. Neuropathologic examination of the cerebellum of individual AAD-
SAL-233-14 (III-9 in Figure 2) 
 
(A - B) Case; (C - D) Control. Hematoxylin and eosin staining. 
(A and C) Granular layer of the cerebellum. The black arrows in (C) point to normal 
glomeruli; normal glomeruli cannot be identified in (A). 
(B and D) Purkinje cell layer. Four normal Purkinje cells are visible in (D), one of 
which is indicated by a black arrow; Purkinje cell loss is severe in (B), only the 
processes of the basket cells are visible ("empty baskets", black arrows). Note the 
additional layer composed of Bergmann glia (white arrows). The asterisk in (B) and 
(D) indicates the molecular layer, which appears loosened in (B). 
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Figure 2. Segregation of the p.Arg1715His change in ADCA pedigrees and 
alignment of orthologs and paralogs 
 
(A) Pedigrees of ADCA families with the p.Arg1715His change. Number of affected 
individuals tested: six in AAD-SAL-233, three in AAD-GRE-319, one in AAD-SAL-
454. All affected but no unaffected individuals harbor the variant in the heterozygous 
state. 
(B) Chromatograms showing the mutation in individuals AAD-SAL-233-9 (III-3), 
AAD-GRE-319-12 (II-2), and AAD-SAL-454-10 (III-1). 
(C) Schematic representation of Cav3.1, showing its organization in four domains, 
each containing six transmembrane segments; segment S4 contains many positively 
charged aminoacids, such as arginine, and is therefore the voltage-sensor. The 
p.Arg1715His change is located in segment S4 of domain IV. Alignment of orthologs 
(D) and paralogs (E) shows that the arginine residues in Cav3.1 are very highly 
conserved across all species, T-type channels, and domains.  
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Figure 3. Electrophysiological analysis of WT and p.Arg1715His Cav3.1 calcium 
channels 
 
(A) Current traces obtained with wild-type (WT) and p.Arg1715His channels at 
various membrane potentials (-90, -80, -70, -65, -60, -55, -50, -45, -40, -35, -30, -25, -
20 mV) and from a holding potential of -100mV. Notice the trace in red (-50mV), 
which shows a smaller current for the pArg1715His channel (36% of the maximum 
current compared with 54% for the WT) 
(B) Averaged current-voltage relationships from traces in panel A. The normalized 
conductance-voltage curve fitted with a Boltzman equation: I/Imax=Gmax(Vm-
Erev)/(1+exp(V1/2-Vm)/k) for each individual cell.  
(C) Steady-state inactivation curves. The curves were fitted using 
I/Imax=1/(1+exp(Vm—V1/2)/k)  
(D) Availability of calcium currents (mean steady-state activation and inactivation 
curves). The steady-state activation curves were fitted with a Boltzmann equation 
G/Gmax=1/(1+exp(V1/2-Vm)/K) were G was calculated as follows: G=I/(Vm-Erev).  
(E and F) Time-constant of inactivation (τ inact) and activation (τ act) kinetics. The 
values were obtained by fitting the traces showed in panel A with a double 
exponential function. 
(G) Recovery from short-term inactivation using a two paired-pulse protocol  
(H) Deactivation kinetics (τ deact).   
(I) Simulation of a DCN neuron firing using the steady state activation and 
inactivation values obtained for the WT (black) and the p.Arg1715His (red) channels. 
The DCN model used was developed by Luthman et al.23 using the NEURON 
simulation environment (https://www.neuron.yale.edu/neuron/), based on the model 
originally implemented in GENESIS by Steuber et al.61 The NaP, HCN and CaLVA 
conductances were changed to match the “Neuron 1” model described by Steuber et 
al.61  
In the above-mentioned equations, V1/2 represents either the half-activation 
potential (steady-state activation curve) or the half-inactivation potential (steady-state 
inactivation curve). Other parameters are Vm, membrane potential; Erev, reversal 
potential; k, slope factor; G, conductance; Gmax, maximum conductance; I, current at 
a given Vm; Imax, maximum current. The extracellular solution contained (in mM): 
135 NaCl, 20 TEACl, 2 CaCl2, 1 MgCl2, 10 HEPES, pH adjusted to 7.44 with KOH. 
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Patch pipettes were filled with an internal solution (140 mM CsCl, 10 mM EGTA, 3 
mM CaCl2, 10 mM HEPES, 3 mM Mg-ATP, 0.6 mM GTP, pH adjusted to 7.25 with 
KOH) and had a typical resistance of 2-3MΩ. From B to H: WT values are 
represented with black circles and p.Arg1715His with red squares. Data are 
represented as mean ± SEM. 

